Study ID: COG ACCL1034
Title:

Impact of Cleansing with Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLA-BSI) and Acquisition of Multi-Drug Resistant Organisms (MDRO) in Children with Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplnation (HCT)

Location:
Sioux Falls Region
Principal Investigator:
Kayelyn Wagner MD
Disease:
AML (Acute Myelogenic Leukemia), Cancer Control, HEME (Hemetologic), CCL, SCT (Stem Cell Transplantation)
Stage:
Phase III

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list